June Liang
June Liang is a member of the Joint Subcommittee of the United States Pharmacopeia Expert Committees on Dosage Forms, Chemical Analysis, Physical Analysis, and Excipients
Articles
Perspectives on Quality Attributes of Drug Products Containing Nanomaterials
Kahkashan Zaidi, PhD;Brent Kleintop;John Hammond;Nancy Lewen;Emmanuel Akala;Anthony Hickey;Jolyon Mitchell;June Liang;Timothy Shelbourn;Katherine Tyner;Eloise Welfare;Norbert Maurer;Munir Hussain;Lawrence Block;Myke Scoggins;Thomas Tice
October 1st 2019In this article, the contents of a stimulus article produced by the joint subcommittee of the USP Expert Committees on Dosage Forms, Physical Analysis, and Excipients and relevant comments from a workshop session are summarized.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: February 23rd 2024 | Updated: December 22nd 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 22nd 2024
FDA Creates CDER Center for Real-World Evidence Innovation
Published: December 5th 2024 | Updated: December 22nd 2024
Leveraging Advancements in Bioanalytical Testing
Published: December 7th 2024 | Updated: December 22nd 2024
Exploring Opportunities for LNP Delivery in mRNA
